stem cell News
-
Optimal oxygen levels for specific stem cell types
Hypoxia maintains the niche where stem cells stay in optimal condition that benefits the self-renewal capacities of human embryonic, mesenchymal, hematopoietic and neural stem cells. In research setting it is very important to understand that the results of any given experiment are only as good as the methods they were produced with. In stem cell biology this is exceptionally important as low ...
By Baker
-
USRM Posts Financial Results for First Quarter 2019
U.S. Stem Cell, Inc. (OTC: USRM), a leader in the development of proprietary, physician-based stem cell therapies and novel regenerative medicine solutions, today announced financial results for the first quarter ended March 31, 2019. For the first time in two years, the Company’s revenue decreased. The drop was 24%, from $1.7M in the first quarter of 2018 to $1.3M in the current quarter. ...
-
Corrected: USRM Posts Earnings for Second Quarter 2019
U.S. Stem Cell, Inc. (OTC: USRM), a leader in the development of proprietary, physician-based stem cell therapies and novel regenerative medicine solutions, today announced earnings for the second quarter that ended June 30, 2019. Correction: U.S. Stem Cell, Inc. posted second-quarter revenues of $1.2M. While second-quarter earnings lagged, the Company’s results took into account the ...
-
McEwen Stem Cell Institute at the University Health Network (UHN) is a global leader in stem cell research and regenerative medicine
Vancouver, BC, Canada - November 30, 2021 - Aspect Biosystems, a biotechnology company pioneering the development of bioprinted cell therapies as medicines of the future, is pleased to announce a research agreement with the University Health Network (UHN). Through this collaboration, Aspect Biosystems will combine its bioprinting technology with UHN’s protocols for differentiating stem ...
-
USRM Posts Earnings for Second Quarter 2019
U.S. Stem Cell, Inc. (OTC: USRM), a leader in the development of proprietary, physician-based stem cell therapies and novel regenerative medicine solutions, today announced earnings for the second quarter that ended June 30, 2019. U.S. Stem Cell, Inc posted second-quarter earnings of $1.2M. While second-quarter earnings lagged, the Company’s results took into account the current regulatory ...
-
USRM Chief Scientist Talks Stem Cell Journey, Autologous Stem Cells with ‘Something Significant’ Happy Living Podcast
U.S. Stem Cell, Inc. (OTC: USRM), a leader in the development of proprietary, physician-based stem cell therapies and novel regenerative medicine solutions, today announced its Chief Science Officer, Dr. Kristin Comella, is featured in the ‘Something Significant’ Happy Living podcast with former NFL player Matt Gersper, where she discusses the inception of her work more than 19 years ...
-
‘Renewing Our Heroes’ to Provide USRM Stem Cell Protocol to First Responders
U.S. Stem Cell, Inc. (OTC: USRM), a leader in the development of proprietary, physician-based stem cell therapies and novel regenerative medicine solutions, today announced Renewing Our Heroes - a charitable health initiative established to provide first responders and other civil service personnel with access to alternative medical care they would otherwise be unable to obtain - will now offer ...
-
How Tomagatchi Hacked the Human Brain
According to an article from Nerdist, “A team of scientists from the University of Cambridge has used the ‘mini brains’ to analyze serious maladies like lateral sclerosis and even dementia. Something they were able to do thanks to stem cells from patients themselves”. Read the full story here: ...
By ni2o, Inc.
-
USRM announces U.S. Stem Cell Clinic Expansion of Products and Services
U.S. Stem Cell Inc, a leader in regenerative medicine products and services, today announced its three partially owned Florida-based clinics have expanded their menu of services to help meet the growing market demand and patient needs for regenerative therapies. In addition to continuing to offer targeted stem cell therapies of all kinds — bone marrow, adipose, and tissue bank products ...
-
Mark Borman appointed Chairman of the Board of USRM
U.S. Stem Cell, Inc. (OTC: USRM), a leader in the development of proprietary, physician-based stem cell therapies and novel regenerative medicine solutions has appointed Mark Borman as Chairman of the Board as Dr. William P. Murphy Jr transitions to Chairman Emeritus. “Mark Borman brings the best of both small-enterprise experience and large-company discipline.. In addition to the valuable ...
-
Adult Stem Cells
Adult stem cells are undifferentiated cells, found throughout the body after embryonic development, which multiply by cell division to replenish dying cells and regenerate damaged tissue. Adult stem cells support tissue and organ turnover throughout life by maintaining a delicate balance between apoptosis and tissue-specific cellular proliferation and differentiation. Adult stem cells reside ...
-
Northstar Biotech and USRM BOD Members Reinvest in the Company
SUNRISE, FL – Feb 23, 2021 – U.S. Stem Cell, Inc. (OTC: USRM), a leader in the development of proprietary, physician-based, and novel regenerative medicine solutions, is pleased to announce the efforts of NorthStar Biotech Group and USRM Board Members to reinvest in U.S. Stem Cell, Inc. On May 9, 2018, the U.S. Department of Justice, at the request of the U.S. Food and Drug ...
-
NIH/NIDDK Phase II SBIR Awarded Sept 2015
Human induced pluripotent stem cell-derived beta-cells for drug and toxicity ...
-
NIH/NCI Small Business Innovation Research Grant, Awarded Fall 2019
Nodexus was selected for an SBIR grant for the development of a novel cancer stem cell detection and isolation platform leveraging the core Nodexus technology ...
By Nodexus Inc.
-
Blood & Stem Cell Donation From Astim
As Astim Family with all our employees, we have become donors for society and life. Turkish Red Crescent, which serves with 67 blood donation centers and mobile blood donation vehicles, with the purpose of meeting whole blood demand from continuous volunteers, was the guest of Astim. In the Red Crescent mobile blood donation vehicle that visited our company, 50% of our total staff that was found ...
By ASTIM A.S.
-
USRM Oral Argument in Appeal from FDA Enforcement Action
SUNRISE, FL – Jan 19, 2021 – U.S. Stem Cell, Inc. (OTC: USRM), a leader in the development of proprietary, physician-based, and novel regenerative medicine solutions, is pleased to announce that oral arguments in the case United States v. U.S. Stem Cell Clinic, LLC, et al., took place on January 13, 2021, before the federal Eleventh Circuit Court of Appeals. The oral argument was ...
-
U.S. Stem Cell Confirms Date for Appeals Court Oral Arguments
U.S. Stem Cell, Inc. (OTC: USRM), a leader in the development of proprietary, physician-based, and novel regenerative medicine solutions, is pleased to announce that oral arguments for the company’s court case USA v. U.S. Stem Cell Clinic, et al has been set for the docket beginning January 11, 2021. Since May 9, 2018, U.S. Stem Cell Inc., as one of the parties named, has been challenged ...
-
Regenerative Medicine
Regenerative medicine is the use of tissue engineering and molecular biology to improve or replace biological function in human cells, tissues and organs. Research on adult stem cells has generated a great deal of excitement in this regard. Despite the challenges in understanding adult stem cell biology, the field of regenerative medicine is taking shape. Developers, FDA regulators ...
-
Aelan collaborates with Gladstone Institutes to conduct comparative study on stem cells
San Francisco, CA - Aelan Cell Technologies today announced they have entered into an agreement with the Gladstone Institutes to further its studies on stem cell rejuvenation. This effort will be led by Meenakshi Gaur, Ph.D. of Aelan Cell Technologies and Kathryn Ivey, Ph.D. of the Gladstone Institutes. Aelan Cell Technologies will be conducting a comparative study that will involve ...
-
US Stem Cell Inc Reports Legal Appeal Results and Company Direction
SUNRISE, FL – June. 8th, 2021 – U.S. Stem Cell, Inc. (OTC: USRM), a corporation that has historically focused on the regenerative medicine / cellular therapy industry specializing in physician training and certification and stem cell products in both human and veterinary stem cell processes , has received the results of the Appeal from the United States 11th District Court for the ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you